Evidence map›Paper›PMID 27121251›Full record

ArticleInternational journal of obesity (2005)2016

miR-200a regulates Rheb-mediated amelioration of insulin resistance after duodenal-jejunal bypass.

W Guo, H Han, Y Wang, X Zhang, S Liu, G Zhang, S Hu

Open access · hybridAbstract read
In one paragraph

Article in International journal of obesity (2005), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Metabolic surgery in China: present and future.Journal of molecular cell biology · 2021
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

W GuoDepartment of General Surgery, Qilu Hospital of Shandong University, Jinan, People's Republic of China.
H HanDepartment of General Surgery, Qilu Hospital of Shandong University, Jinan, People's Republic of China.
Y WangDepartment of General Surgery, Qilu Hospital of Shandong University, Jinan, People's Republic of China.
X ZhangDepartment of General Surgery, Qilu Hospital of Shandong University, Jinan, People's Republic of China.
S LiuDepartment of General Surgery, Qilu Hospital of Shandong University, Jinan, People's Republic of China.
G ZhangDepartment of General Surgery, Qilu Hospital of Shandong University, Jinan, People's Republic of China.
S HuDepartment of General Surgery, Qilu Hospital of Shandong University, Jinan, People's Republic of China.
Qilu Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDuodenal-jejunal bypass (DJB) surgery can induce the rapid and durable remission of diabetes. Recent studies indicate that ameliorated hepatic insulin resistance and improved insulin signaling might contribute to the diabetic control observed after DJB. Ras homolog enriched in brain (Rheb) is reported to have an important role in insulin pathway, and some microRNAs (miRNAs) have been found to regulate Rheb. This study was conducted to investigate the effects of DJB on hepatic insulin resistance and the effects of miRNA-200a, a Rheb-targeting miRNA, on the development of DJB-induced amelioration in hepatic insulin resistance. SUBJECTS: We investigated hepatic insulin signaling change and mapped the hepatic miRNAome involved in a rat model of DJB. We studied the effects of miR-200a on Rheb signaling pathway in buffalo rat liver cell lines. Liver tissues were studied and glucose tolerance tests were conducted in DJB rats injected with lentivirus encoding miR-200a inhibitor and diabetic rats injected with miR-200a mimic.

resultsRheb is a potential target of miR-200a. Transfection with an miR-200a inhibitor increased Rheb protein levels and enhanced the feedback action on insulin receptor substrate-dependent insulin signaling, whereas transfection with an miR-200a mimic produced the opposite effects. A luciferase assay confirmed that miR-200a bind to the 3'UTR (untranslated regions) of Rheb. Global downregulation of miR-200a in DJB rats showed impaired insulin sensitivity whereas upregulation of miR-200a in diabetic rats showed amelioration of diabetes.

conclusionsA novel mechanism was identified, in which miR-200a regulates the Rheb-mediated amelioration of insulin resistance in DJB. The findings suggest miR-200a should be further explored as a potential target for the treatment of diabetes.

Indexed as

Bariatric SurgeryAnimalsBlood GlucoseBlotting, WesternCell LineCell ProliferationDiabetes Mellitus, Type 2Disease Models, AnimalDuodenumGene Expression RegulationImmunohistochemistryInsulinInsulin ResistanceJejunumLiverMaleBlood GlucoseInsulinMicroRNAsMIRN200 microRNA, ratRas Homolog Enriched in Brain ProteinRheb protein, rat

Identifiers

PMID27121251
PMCPMC4973218
OpenAlexW2344977660

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.